Price Caps on Diabetes Medications & Management Equipment
The Issue
11.3% of the U.S. population is diagnosed with diabetes
Diabetes accounts for 280,000 deaths annually in the US.
~96 million adults in the United States are pre-diabetic
In the face of our nation’s growing diabetes epidemic, the soaring costs of insulin and essential diabetes management tools threaten the health, well-being, and financial stability of countless individuals.
Today, many people living with diabetes must navigate a harsh reality where high medication costs force them to make impossible choices—rationing their insulin, sacrificing life necessities, or even risking their health.
Affordability Crisis:
The price of insulin has more than tripled over the past two decades, rising from an average cost of approximately $30 to $60 per month in the early 2000s to over $600 per month by 2021.
Insulin prices:
- With insurance: $25-100 per month supply
- Without: $300-800 per month supply
When production costs $3-6 per month supply (1000 units).
Continuous glucose monitors, insulin pumps, and other necessary devices are critical for effective diabetes management.
As these costs rise, patients often find themselves without the tools needed to maintain their health.
The prices of diabetes devices, such as continuous glucose monitors and insulin pumps, have surged in recent years, with continuous glucose monitors increasing from about $300 in 2016 to approximately $400-$700 by 2020, and insulin pumps rising from $4,000 to over $9,000 for advanced models between 2010 and 2021.
- Production costs for diabetes devices, such as continuous glucose monitors and insulin pumps, are relatively low, typically ranging from $30 to $100 per unit, yet prices in the market can exceed several thousand dollars.
Insurance coverage for diabetes medications and devices varies, with most insurers providing some reimbursement, while uninsured individuals can find free supplies through organizations like the American Diabetes Association and NeedyMeds.
However, this assistance is inadequate; given the low production costs, implementing price caps is vital for improving access to essential medications and tools for many lives.
Particularly as numerous barriers persist beyond cost, including lack of awareness, limited availability, logistical challenges, and fears that deter many from seeking the care and resources they need.
Ensuring affordable access to insulin and management devices will prevent serious health complications associated with poorly managed diabetes, ultimately reducing healthcare costs for families and the broader healthcare system.
The pursuit of affordable insulin and comprehensive diabetes care is fundamentally a fight for health equity, ensuring that all individuals, regardless of their situations/background, have access to essential resources necessary for their survival.
Your Signature is Powerful!
We urge you to support and sponsor legislation that establishes price caps on insulin and diabetes management equipment, ensuring that no individual has to choose between their health and financial well-being.
Please consider the voices of your constituents who are affected by this crisis and act to address this urgent need. Together, we can create a future where all individuals living with diabetes have access to the medications and resources they require to thrive.
51
The Issue
11.3% of the U.S. population is diagnosed with diabetes
Diabetes accounts for 280,000 deaths annually in the US.
~96 million adults in the United States are pre-diabetic
In the face of our nation’s growing diabetes epidemic, the soaring costs of insulin and essential diabetes management tools threaten the health, well-being, and financial stability of countless individuals.
Today, many people living with diabetes must navigate a harsh reality where high medication costs force them to make impossible choices—rationing their insulin, sacrificing life necessities, or even risking their health.
Affordability Crisis:
The price of insulin has more than tripled over the past two decades, rising from an average cost of approximately $30 to $60 per month in the early 2000s to over $600 per month by 2021.
Insulin prices:
- With insurance: $25-100 per month supply
- Without: $300-800 per month supply
When production costs $3-6 per month supply (1000 units).
Continuous glucose monitors, insulin pumps, and other necessary devices are critical for effective diabetes management.
As these costs rise, patients often find themselves without the tools needed to maintain their health.
The prices of diabetes devices, such as continuous glucose monitors and insulin pumps, have surged in recent years, with continuous glucose monitors increasing from about $300 in 2016 to approximately $400-$700 by 2020, and insulin pumps rising from $4,000 to over $9,000 for advanced models between 2010 and 2021.
- Production costs for diabetes devices, such as continuous glucose monitors and insulin pumps, are relatively low, typically ranging from $30 to $100 per unit, yet prices in the market can exceed several thousand dollars.
Insurance coverage for diabetes medications and devices varies, with most insurers providing some reimbursement, while uninsured individuals can find free supplies through organizations like the American Diabetes Association and NeedyMeds.
However, this assistance is inadequate; given the low production costs, implementing price caps is vital for improving access to essential medications and tools for many lives.
Particularly as numerous barriers persist beyond cost, including lack of awareness, limited availability, logistical challenges, and fears that deter many from seeking the care and resources they need.
Ensuring affordable access to insulin and management devices will prevent serious health complications associated with poorly managed diabetes, ultimately reducing healthcare costs for families and the broader healthcare system.
The pursuit of affordable insulin and comprehensive diabetes care is fundamentally a fight for health equity, ensuring that all individuals, regardless of their situations/background, have access to essential resources necessary for their survival.
Your Signature is Powerful!
We urge you to support and sponsor legislation that establishes price caps on insulin and diabetes management equipment, ensuring that no individual has to choose between their health and financial well-being.
Please consider the voices of your constituents who are affected by this crisis and act to address this urgent need. Together, we can create a future where all individuals living with diabetes have access to the medications and resources they require to thrive.
The Decision Makers
Supporter Voices
Petition Updates
Share this petition
Petition created on November 27, 2024